2025-10-31 17:29:03
Latest Post
Medanta Super Speciality Hospital performs Bhoomi Poojan of its Upcoming Hospital in Guwahati
Firstsource and Monash University Sign Strategic MoU
Deep Diamond India Limited declares interim dividend of Rs. 0.10
Steelcast Ltd declares 2nd interim dividend of Rs. 0.36
Lancor Holdings Ltd gets favorable verdict from SC in commercial property case
Stock Report
Sumitomo Chemical India Ltd consolidated Q2FY26 PAT at Rs. 177.76 crores
Posted On : 2025-10-27 14:12:28( TIMEZONE : IST )
Sumitomo Chemical India Limited has reported Consolidated financial results for the period ended September 30, 2025.
Financial Results (Q2 FY2026) - QoQ Comparison
The company has reported total income of Rs. 968.617 crores during the period ended September 30, 2025 as compared to Rs. 1095.565 crores during the period ended June 30, 2025.
The company has posted net profit / (loss) of Rs. 177.765 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs. 178.339 crores for the period ended June 30, 2025.
The company has reported EPS of Rs. 3.56 for the period ended September 30, 2025 as compared to Rs. 3.57 for the period ended June 30, 2025.
| Financials | Q2 FY2026 | Q1 FY2026 | % Change |
| Total Income | ₹ 968.617 crs | ₹1095.565 crs |  -11.59% |
| Net Profit | ₹177.765 crs | ₹178.339 crs | -0.32% |
| EPS | ₹3.56 | ₹3.57 | -0.28% |
Financial Results (Q2 FY2026) - YoY Comparison
The company has reported total income of Rs. 968.617 crores during the period ended September 30, 2025 as compared to Rs.1019.532 crores during the period ended September 30, 2024.
The company has posted net profit / (loss) of Rs.177.765 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs.192.286 crores for the period ended September 30, 2024.
The company has reported EPS of Rs.3.56 for the period ended September 30, 2025 as compared to Rs.3.85 for the period ended September 30, 2024.
| Financials | Q2 FY2026 | Q2 FY2025 | % Change |
| Total Income | ₹ 968.617 crs | ₹1019.532 crs | -4.99% |
| Net Profit | ₹177.765 crs | ₹192.286 crs | -7.55% |
| EPS | ₹3.56 | ₹3.85 | -7.53% |
Financial Results (Half Year Ended FY2026) - YoY Comparison
The company has reported total income of Rs.2064.182 crores during the 6 Months period ended September 30, 2025 as compared to Rs.1884.430 crores during the 6 Months period ended September 30, 2024.
The company has posted net profit / (loss) of Rs.356.104 crores for the 6 Months period ended September 30, 2025 as against net profit / (loss) of Rs.318.962 crores for the 6 Months period ended September 30, 2024.
The company has reported EPS of Rs.7.13 for the 6 Months period ended September 30, 2025 as compared to Rs.6.39 for the 6 Months period ended September 30, 2024.
| Financials | Half Year Ended FY2026 | Half Year Ended FY2025 | % Change |
| Total Income | ₹2064.182 crs | ₹1884.430 crs |  9.54% |
| Net Profit | ₹356.104 crs | ₹318.962 crs | 11.64% |
| EPS | ₹7.13 | ₹6.39 | 11.58% |
Shares of Sumitomo Chemical India Limited was last trading in BSE at Rs. 518.55 as compared to the previous close of Rs. 518.95. The total number of shares traded during the day was 9766 in over 423 trades.
The stock hit an intraday high of Rs. 520.15 and intraday low of 514.60. The net turnover during the day was Rs. 5054030.00.
